@article{APC4896,
author = {Jessica L. Buicko and Brendan M. Finnerty and Tiantian Zhang and Bu Jung Kim and Thomas J. Fahey III and Yi-Chieh Nancy Du},
title = {Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors},
journal = {Annals of Pancreatic Cancer},
volume = {2},
number = {0},
year = {2019},
keywords = {},
abstract = {Pancreatic neuroendocrine tumors (PNETs) are the second most common primary pancreatic neoplasms after pancreatic ductal adenocarcinoma. PNETs present with widely various clinical manifestation and unfavorable survival rate. The recent advances in next generation sequencing have significantly increased our understanding of the molecular landscape of PNETs and help guide the development of targeted therapies. This review intends to outline a holistic picture of the tumors by discussing current understanding of clinical presentations, up-to-date treatment strategies, novel mouse models, and molecular biology of PNETs. Furthermore, we will provide insight into the future development of more effective targeted therapies that are necessary to manage PNETs.},
issn = {2616-2741}, url = {https://apc.amegroups.org/article/view/4896}
}